Â
Latest Hormone Replacement Therapy Companies Update
Jan 2024Pfizer launched their new Estrodiol oral tablet with a unique delivery system for controlled release and improved symptom management.
Merck KGaA partnered with a research institution to develop a personalized HRT approach based on individual genetic and hormonal profiles.
Novartis AG received FDA approval for their new transdermal testosterone patch for men with hypogonadism, expanding their HRT offerings beyond women.
AbbVie focused on educational initiatives and awareness campaigns to improve understanding and accessibility of HRT for women considering treatment options.
TherapeuticsMD announced positive results from clinical trials of their investigational oral progesterone product for menopause management, potentially offering a safer and more convenient alternative.
List of Hormone Replacement Therapy Key Companies in the Market
- Bayer AG
- Pfizer Inc.
- Merck & Co., Inc.
- Viatris, Inc.
- Novo Nordisk A/S
- Eli Lilly and Company
- Hoffmann-La Roche Ltd
- Noven Pharmaceuticals, Inc.
- ASCEND Therapeutics US, LLC.
- AbbVie Inc.